Sep 10, 2018 06:16PM
Sep 10, 2018 01:10PM
Sep 10, 2018 08:47AM
Sep 10, 2018 04:30AM
Aug 24, 2018 08:32AM
Aug 24, 2018 04:30AM
Jun 6, 2018 08:07AM Shire launches screen responsibly, an eyelove® initiative dedicated to prioritizing eye health in a screen-saturated world
May 15, 2018 07:00AM
Mar 6, 2018 08:02AM
Mar 6, 2018 08:00AM
Jun 22, 2017 01:00AM
Jun 20, 2017 06:48PM
May 19, 2017 01:00AM
May 18, 2017 09:08AM Shire (SHPG) Says Lancet Publishes Phase 2 Results from Anti-MAdCAM Antibody Showing Increased Remission Rates in Patients with Moderate-to-Severe UC
May 18, 2017 09:00AM
May 18, 2017 07:07AM
May 18, 2017 07:00AM
May 16, 2017 07:00AM
May 2, 2017 07:00AM
May 1, 2017 07:09AM
May 1, 2017 07:00AM Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for Ophthalmic Indications
Apr 26, 2017 06:27AM
Apr 26, 2017 01:00AM
Apr 17, 2017 01:00AM
Mar 30, 2017 06:46AM
Mar 30, 2017 04:41AM
Mar 22, 2017 07:08AM
Mar 22, 2017 07:00AM Shire Receives FDA Fast Track Designation for Recombinant ADAMTS13 (SHP655) for Treatment of Hereditary Thrombotic Thrombocytopenic Purpura
Mar 16, 2017 02:00AM
Mar 6, 2017 01:57PM
Mar 6, 2017 01:55PM
Feb 24, 2017 07:22AM
Feb 24, 2017 07:17AM
Feb 23, 2017 06:42AM
Feb 23, 2017 04:11AM New England Journal of Medicine Publishes Phase 1b Results for Shire's Investigational Treatment for Hereditary Angioedema, a Rare Genetic Disease
Feb 16, 2017 07:52AM
Feb 14, 2017 07:30AM
Feb 7, 2017 03:47PM
Feb 7, 2017 03:42PM
Feb 1, 2017 01:39PM
Jan 19, 2017 07:02AM
Jan 19, 2017 07:00AM U.S. FDA Acknowledges Receipt of Shire's New Drug Application for SHP465 for ADHD
Dec 27, 2016 07:04AM
Dec 27, 2016 07:00AM
Dec 5, 2016 07:55AM
Dec 2, 2016 05:21PM
Dec 2, 2016 11:06AM
Dec 2, 2016 11:02AM
Nov 16, 2016 07:02AM Shire (SHPG) Announces U.S. Launch of CUVITRU
Nov 16, 2016 07:00AM

1,155,356 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All